« Previous
Next »
Thrombosis Research
Volume 125, Issue 6
, Pages 545-548
, June 2010
A Novel Mutation (G2172→C) in the Factor V Gene in a Chinese Family with Hereditary Activated Protein C Resistance
References
- . The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem. 1989;264:4743–4746
- . Impairment of the protein C anticoagulant pathway in a patient with systemic lupus erythematosus, anticardiolipin antibodies and thrombosis. Thromb Res. 1990;57:247–258
- . Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993;90:1004–1008
- . Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 1994;343:1536–1538
- Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–67
- . Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet. 1994;343:1361–1362
- Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117:19–25
- A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood. 2002;99:2720–2725
- . The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica. 2007;92:1107–1114
- . Laboratory evaluation and clinical characteristics of 2, 132 consecutive unselected patients with venous thromboembolism–results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost. 1997;77:444–451
- . Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677
T, and population genetics. Mol Genet Metab. 2005;86:91–99 - . Factor V Leiden and PTG20210A gene mutation in patients with venous thrombosis and healthy blood donors. Zhonghua Yi Xue Za Zhi. 1999;79:900–902
- Analysis of activated protein C resistance, factor V coagulation activity and gene polymorphisms in patients with venous thromboembolism. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007;15:612–616
- . Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol. 2006;28:111–116
- Factor V Leiden mutation in one family of Chinese origin. Chin Med J (Engl). 2001;114:379–381
- . Factor V Cambridge: a new mutation (Arg306--
>
Thr) associated with resistance to activated protein C. Blood. 1998;91:1140–1144 - Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci U S A. 1987;84:4846–4850
- . Coagulation factor V and thrombophilia: background and mechanisms. Thromb Haemost. 2007;98:530–542
- . Factor V Leiden: a disorder of factor V anticoagulant function. Curr Opin Hematol. 2004;11:176–181
- . A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood. 1998;91:1135–1139
- . Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations. Blood. 2004;103:4173–4179
- . Functional characterization of recombinant FV Hong Kong and FV Cambridge. Blood. 2002;100:524–530
- Antithrombin, Protein C, Protein S and Activated Protein C Resistance in the General Healthy Chinese Population: Normal Plasmatic Ranges and Genetic Defects. Blood. 2007;110:63B;Abstract
PII: S0049-3848(10)00147-7
doi: 10.1016/j.thromres.2010.02.009
© 2010 Elsevier Ltd. All rights reserved.
« Previous
Next »
Thrombosis Research
Volume 125, Issue 6
, Pages 545-548
, June 2010
